The board of a large listed manufacturer must decide how to respond when its chief executive faces allegations about undisclosed personal relationships while an independent investigation is under way. The log compares retaining the chief executive, a leave of absence, accepting resignation with an interim chief executive and an independent chair, and naming a permanent successor at once. Readers can see how investigation exposure, operational continuity, stakeholder confidence, succession quality, board independence and reversibility trade off, and how the proposed interim route is governed, implemented and reviewed.
A commercial computing hardware supplier considers four routes to emerging specialist capabilities: internal development, licensing, co-development with an equity-linked partner, or acquisition. The log examines how technical access, investment exposure, architecture control, delivery speed, dependence and uncertainty shape a commercial technology strategy. The proposed joint-development route includes governance, implementation and review conditions.
A large research-based pharmaceutical manufacturer decides how to pay for the pivotal clinical programme of its lead candidate in a highly prevalent chronic metabolic indication, at a point when several of its largest products are approaching the end of exclusivity. The log compares full internal funding, co-funding by a financial partner against success-based payments, sale of a participation in future product sales, a co-development and commercialisation agreement with another manufacturer, and a reduced programme funded internally. Options are compared on own development spend, lifetime economics retained, control of development and pricing, exposure if the programme fails, encumbrance on product assets, breadth of the evidence package and time until funding is in place. Readers can see how a financing choice is also a control and evidence-strategy choice, and how contingent, success-linked obligations are weighed against permanent claims on a product.
research and development funding, risk transfer, control and governance rights, evidence strategy, portfolio capacity
A large listed consumer-products group decides how to exit a mature unit that is no longer a priority. The comparison covers retaining the unit, a spin-off, a sale with a retained minority stake and an outright sale, against net cash, time to completion, retained upside, management focus, execution risk and residual exposure. The sale with a retained minority stake is proposed, with protections, debt-reduction use of proceeds and reassessment conditions.
portfolio management, divestiture structure, capital allocation, leverage reduction, separation risk
A listed fabless chip supplier weighs four routes to obtaining a critical component capability as data-centre links change technology: partnership, full share-funded acquisition, minority stake and organic build. Readers can see how control of supply, customer conflict, integration risk, dilution and regulatory exposure trade off against speed and cost.
A decision log on how a large manufacturer of cyclical heavy machinery can respond to a prolonged demand downturn that leaves two older plants far below normal volumes. It compares holding, phased domestic consolidation, offshoring and contract manufacture on cost, speed, workforce impact, supply risk and reversibility, and shows how rationale, governance, actions and review conditions attach to the proposed course.
capacity and footprint strategy, restructuring in a downturn, workforce transition, supply chain risk
A farmer-owned producer cooperative decides how to structure a bid for a branded packaged-food group being sold by financial sponsors: alone, for the core brands only with a partner, jointly with a domestic peer, or not at all. Readers can see how capital exposure, balance-sheet strain, competition clearance risk, timing, ownership-policy fit and strategic scale trade off, and how a joint bid is conditioned on a binding brand split and licensor consent.
acquisition structure, consortium bidding, merger control, capital allocation, stakeholder alignment
A vehicle component manufacturer decides whether machine vision should replace, support or leave alone the inspectors who check every part before despatch. The log shows why a single accuracy figure i...
A mid-sized European manufacturer decides how to source a component fitted to every unit it builds, weighing a sole-source renewal, two sole-source alternatives and a dual-source split. The log shows ...